SUCCEED Kids
Summary
Children with autoimmune diseases and autoinflammatory conditions may be at risk of disease flares in response to immune system triggers, including vaccines. With this in mind, it is not clear whether there might be significant side effects or flares in children with autoimmune diseases after receiving a COVID-19 vaccination. In addition, it is not clear how medication use, such as biologic therapy, in children with childhood arthritis may affect the response to COVID-19 vaccinations.
Our team of researchers believes that studying childhood arthritis is key to providing better patient care, as well as improving quality of life and health outcomes of children suffering with these conditions.
Eligibility
Eligible gender: Male, Female, Transgender, Other
Accepts healthy participants: Yes
Inclusion criteria:
Participants for the study will be recruited from pediatric hospitals across Canada.
There are four different groups we will evaluate based on current medication therapies and disease diagnosis.
If you/your child are ≤18 years of age at the time of study enrollment and have an autoimmune disease, you may be eligible for the study.
If you are interested in participating, please talk to your Rheumatologist about SUCCEED Kids!
Participate
Additional information
Contact information
During the pilot phase recruitment for this study was completed through physician referral. Recruitment will be expanded to include self referral after study introduction via advocacy group information sessions.
Principal investigator:
Susanne Benseler
Clinical trial:
No
REB-ID:
REB21-1788